Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.57 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.57 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 9/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3398154 | 0.90 | MAPT (0.61) | CDC25BNPC1RAB9ACNR2MAPT | |
| SCHEMBL29414437 | 0.88 | CDC25B (0.80) | CDC25BNR4A1NR4A2NR4A3CNR2 | |
| SCHEMBL244802 | 0.88 | CDC25B (0.80) | CDC25BNR4A1NR4A2NR4A3CNR2 | |
| SCHEMBL6024393 | 0.87 | CDC25B (0.59) | CDC25BNPC1RAB9ANR4A1NR4A2 | |
| SCHEMBL7637780 | 0.86 | CDC25B (0.57) | CDC25BNPC1RAB9ANR4A1NR4A2 | |
| SCHEMBL112507 | 0.83 | MAPT (0.74) | NPC1RAB9AMAPTGAAALDH1A1 | |
| SCHEMBL30790667 | 0.83 | MAPT (0.74) | NPC1RAB9AMAPTGAAALDH1A1 | |
| SCHEMBL29068807 | 0.81 | CDC25B (0.51) | CDC25BNPC1RAB9ANR4A1NR4A2 | |
| Ammonia Solution, Strong SCHEMBL10992665 | 0.81 | MAPT (0.71) | NPC1RAB9AMAPTGAAALDH1A1 | |
| Hydrochloric Acid SCHEMBL11745887 | 0.81 | MAPT (0.71) | NPC1RAB9AMAPTGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115947690-B | Preparation method of indazole molecular building block and application of indazole molecular building block in drug synthesis | 安徽医科大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-115947690-A | Preparation method of indazole molecular building block and application of building block in drug synthesis | 安徽医科大学 | 2023-04-11 | — | — | CN | disclosed |
| EP-2479160-B1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | UNIV OSAKA (JP) | 2015-09-09 | — | — | EP | disclosed |
| EP-2479160-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | Osaka University (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | OSAKA UNIVERSITY (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | OSAKA UNIVERSITY (JP) | 2012-07-05 | — | — | US | disclosed |
| US-7977486-B2 | Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives | OSAKA UNIVERSITY (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977486-B2 | Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives | OSAKA UNIVERSITY (JP) | 2011-07-12 | — | — | US | disclosed |
| WO-2011034071-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | 国立大学法人大阪大学 (JP) | 2011-03-24 | — | — | WO | disclosed |
| US-20100004454-A1 | QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES | OSAKA UNIVERSITY (JP) | 2010-01-07 | — | — | US | disclosed |
| EP-0914392-A1 | LUMINESCING INKS AND USE OF SUCH INKS IN CODING AND OTHER MARKING OPERATIONS | THE POST OFFICE (GB) | 1999-05-12 | — | — | EP | disclosed |
| US-5858571-A | TREATING A PULVERIZED HYDROGEN ABSORBING ALLOY WITH A SOLUTION COMPRISING A CONJUGATED UNSATURATED COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0872903-A1 | Method for making hydrogen storage alloy powder and electrode comprising the alloy powder | Shin-Etsu Chemical Co., Ltd. (JP) | 1998-10-21 | — | — | EP | disclosed |
| WO-1998003596-A1 | LUMINESCING INKS AND USE OF SUCH INKS IN CODING AND OTHER MARKING OPERATIONS | THE POST OFFICE (GB) | 1998-01-29 | — | — | WO | disclosed |
| CN-1006386-B | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | SHINETSU CHEM IND CO (JP) | 1990-01-10 | — | — | CN | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| CN-85107531-A | Process for producing vinyl chloride polymer | — | 1987-01-21 | — | — | CN | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120171111-A1 | PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND | TYR, AOX1, POR | CDC25B 3846/4885NPC1 3211/4885RAB9A 2446/4885 |
| US-20100004454-A1 | QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES | APEX1, NQO1, POT1 | CDC25B 3331/4885NPC1 3576/4885RAB9A 740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.